好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Biomarker Screening for Alzheimer's Disease: The Impact of Sensitivity and Specificity Parameters
Aging and Dementia
(-)
119
Authors/Disclosures
Kristin Kahle-Wrobleski No disclosure on file
Eric R. Siemers, MD (Siemers Integration LLC) Dr. Siemers has received personal compensation for serving as an employee of Acumen Pharmaceuticals. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Vaccinex Pharmceuticals. The institution of Dr. Siemers has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cogstate Ltd. The institution of Dr. Siemers has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Gates Ventures LLC. The institution of Dr. Siemers has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for US Green Valley Pharmaceuticals, Inc. Dr. Siemers has stock in Acumen Pharmaceuticals. Dr. Siemers has stock in Ell Lilly and Company. Dr. Siemers has received personal compensation in the range of $0-$499 for serving as a study section reviewer with National Institutes of Health. Dr. Siemers has a non-compensated relationship as a Volunteer with Alzheimer's Association that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Bright Focus Foundation that is relevant to AAN interests or activities. Dr. Siemers has a non-compensated relationship as a Board of Directors with Huntington Study Group that is relevant to AAN interests or activities.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Ayse Sagduyu No disclosure on file
No disclosure on file
No disclosure on file